NatiVita Pharmaceutical Company has been developing innovative medications since 2012. Today, the company poses as an international research and manufacturing site drawing in state-of-the art innovative biotechnology solutions from many countries. The company has such partners in the technology field, as Biomed (Slovakia), Unipharma (Slovakia), Natco Pharma Ltd (India), Generium (Russia), Vitebsk State Medical University, Comenius University in Bratislava, in particular, the Jessenius Faculty of Medicine and Biomedical Center in Martin (Slovakia), Genetic Engineering and Biotechnology Center (Cuba).
NatiVita medications have been successfully registered on the domestic market and they have been actively used for cancer therapy. A number of new drugs are being developed at the moment; very soon, new medications will be on offer for treatment of patients with serious diseases.